Westfuller Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Westfuller Advisors's NVS Position: Q3 2026 in Review
Westfuller Advisors reduced its Novartis (NVS) stake by 25% in Q3 2026, selling an estimated $5.92K and leaving 117 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #402.
Westfuller Advisors first reported a position in NVS in Q3 2025 and has held it in 5 quarters since. The position peaked at $224K in Q4 2025. 1,548 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Westfuller Advisors held 117 shares of Novartis worth $16.6K as of Q3 2026.
- Westfuller Advisors sold 39 Novartis shares in Q3 2026, an estimated $5.92K.
- Novartis made up ﹤0.01% of Westfuller Advisors's portfolio in Q3 2026, its #402 holding.
- Westfuller Advisors first reported a position in Novartis in Q3 2025 and has held it in 5 quarters since.
- Westfuller Advisors's Novartis position peaked at $224K in Q4 2025.
- 1,548 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Westfuller Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.